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Tri- and tetra-nuclear polypyridyl ruthenium(II)
complexes as antimicrobial agents
Anil K. Gorle,a Marshall Feterl,b,c Jeffrey M. Warner,b,c Lynne Wallace,a
F. Richard Keene*c,d,e and J. Grant Collins*a
A series of inert tri- and tetra-nuclear polypyridylruthenium(II) complexes that are linked by the bis[4(4’-
methyl-2,2’-bipyridyl)]-1,n-alkane ligand (“bbn” for n = 10, 12 and 16) have been synthesised and their
potential as antimicrobial agents examined. Due to the modular nature of the synthesis of the oligonuc-
lear complexes, it was possible to make both linear and non-linear tetranuclear ruthenium species. The
minimum inhibitory concentrations (MIC) of the ruthenium(II) complexes were determined against four
strains of bacteria − Gram positive Staphylococcus aureus (S. aureus) and methicillin-resistant S. aureus
(MRSA), and Gram negative Escherichia coli (E. coli) and Pseudomonas aeruginosa (P. aeruginosa). In
order to gain an understanding of the relative antimicrobial activities, the cellular uptake and water–
octanol partition coefficients (log P) were determined for a selection of the ruthenium complexes.
Although the trinuclear complexes were the most lipophilic based upon log P values and showed the
greatest cellular uptake, the linear tetranuclear complexes were generally more active, with MIC values
<1 μM against the Gram positive bacteria. Similarly, although the non-linear tetranuclear complexes were
slightly more lipophilic and were taken up to a greater extent by the bacteria, they were consistently less
active than their linear counterparts. Of particular note, the cellular accumulation of the oligonuclear
ruthenium complexes was greater in the Gram negative strains compared to that in the Gram positive
S. aureus and MRSA. The results demonstrate that the lower antimicrobial activity of polypyridylruthenium(II)
complexes towards Gram negative bacteria, particularly P. aeruginosa, is not strongly correlated to the cel-
lular accumulation but rather to a lower intrinsic ability to kill the Gram negative cells.
Introduction
Infectious diseases remain a leading cause of death worldwide,
and as there is also an increasing emergence of drug-resistant
bacteria1 it is clear that there is a need for new antimicrobial
agents. Based upon the versatile nature of transition metal
complexes and their recent success as anticancer agents,2–4
there has been growing interest in their use as antimicrobial
agents, and in particular ruthenium complexes have been
widely examined.5–10 Dwyer and his co-workers first reported
the antimicrobial potential of mononuclear iron and ruthe-
nium complexes containing polypyridyl ligands.11,12 However,
while these complexes exhibited excellent activity against drug-
sensitive strains, they were significantly less active against
current drug-resistant strains.13 In an attempt to increase the
activity of inert polypyridylruthenium complexes against drug-
resistant bacteria, we have examined the antimicrobial pro-
perties of inert and chlorido-containing dinuclear ruthenium
and iridium metal analogues.13–15 The inert dinuclear polypyri-
dylruthenium(II) complexes [{Ru(phen)2}2{μ-bbn}]4+ {“Rubbn”;
where phen = 1,10-phenanthroline; bbn = bis[4(4′-methyl-2,2′-
bipyridyl)]-1,n-alkane for n = 5, 7, 10, 12 and 16} showed excel-
lent activity, with minimum inhibitory concentrations (MIC) of
1 and 2 µg mL−1 for the Rubb12 and Rubb16 complexes against
a range of Gram positive and Gram negative bacterial strains,
and they maintained the activity against drug-resistant strains
such as methicillin-resistant Staphylococcus aureus (denoted as
MRSA).13 Furthermore, preliminary toxicity assays against
human red blood cells and a human monocytic leukemia cell
line (THP-1) indicated that the Rubbn complexes were not sig-
nificantly toxic to human cells.13
The inert dinuclear Rubbn complexes with an overall charge
of 4+ can interact reversibly with various intra-cellular recep-
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tors such as proteins and nucleic acids to stop bacterial cell
replication. Rubb16 was shown to condense ribosomes when
they existed as polysomes, and it was postulated that the con-
densation of polysomes would halt protein production and
thereby inhibit bacterial growth.16 Although it would be
expected that complexes which have a higher positive charge
would condense polysomes more efficiently, cellular uptake
experiments with mononuclear and dinuclear polypyridyl-
irdium(III) complexes (3+ and 6+ respectively) demonstrated
that they could not easily cross the cellular membrane, and
hence they showed no antimicrobial activity.15,17 An alternative
approach of increasing the charge of the dinuclear ruthenium
complexes is to synthesise tri- and tetra-nuclear species. While
the tri- and tetra-nuclear ruthenium complexes will be more
positively charged – 6+ and 8+ respectively – they will also be
more lipophilic than the dinuclear counterparts due to the
additional non-polar linking ligands. Preliminary experiments
with the tri- and tetra-nuclear complexes of Rubb7 demon-
strated the potential of this approach.13 The Rubb7-tri and
Rubb7-tetra were 2–4 times more active against a range of bac-
teria than the corresponding dinuclear Rubb7.
Over the last decade there has been considerable interest in
developing inert dinuclear ruthenium(II) complexes as nucleic
acid binding probes, anticancer agents and cellular imaging
agents.18–27 More recently, there has been increasing interest
in using higher nuclearity ruthenium complexes as anticancer
agents.28–30 Predominantly, research has focused on ruthe-
nium clusters or cages, as these bulky complexes may preferen-
tially accumulate in tumours due to the enhanced
permeability and retention effect.28–30 Alternatively, while
several tri- and tetra-nuclear copper(II) complexes with modest
antimicrobial activities have been reported,31,32 there have
been very few studies on the potential of tri- or tetra-nuclear
ruthenium complexes as antimicrobial agents. In the present
study, we aimed to synthesise the tri- and tetra-nuclear ana-
logues of the most active dinuclear complexes, Rubb12 and
Rubb16, and examine their antimicrobial activities, log P values
and cellular uptake. Additionally, due to the modular nature of
the synthesis of these complexes, it was possible to synthesise
both linear and non-linear tetranuclear complexes. The struc-
tures of the multinuclear complexes and the important precur-
sor complex Rubbn-Cl2, which was also examined for
antimicrobial activity, are shown in Fig. 1. The results of this
study indicate that inert tri- and tetra-nuclear ruthenium poly-
pyridyl complexes can be highly active antimicrobial agents.
Results
Synthesis
The synthesis of flexibly-linked dinuclear (Rubbn-Cl2), trinuc-
lear (Rubbn-tri), tetranuclear (Rubbn-tetra) and non-linear
tetranuclear (Rubbn-tetra-nl) ruthenium complexes incorporat-
ing bis[4′-(4-methyl-2,2′-bipyridyl)]-1,n-alkane bridging ligands
(bbn) has been achieved in good yield, as shown in Schemes 1
and 2. The chlorido-containing dinuclear species (Rubbn-Cl2)
were synthesised by reacting the mononuclear complex,
Rubbn-mono, with (phenH
+)[Ru(phen)Cl4] in DMF at reflux
temperature. The characterisation of the chlorido complexes
was carried out by NMR spectroscopy and they were used as
precursors for the synthesis of the tri- and tetra-nuclear
complexes.
The trinuclear and tetranuclear (both linear and non-linear)
complexes were characterised by microanalysis, NMR (1H and
13C) and high resolution electrospray ionisation mass spec-
troscopy methods. Consistent with the observations previously
reported for Rubb7-tetra,
33 satisfactory ESI-MS could not be
obtained for the linear tetranuclear complexes when they were
dissolved in acetonitrile. However, good mass spectra could be
obtained using acetone as the solvent. The synthesis of non-
linear complexes was achieved by the reaction between the
mononuclear complex, Rubbn-mono, and cis-[Ru(DMSO)4Cl2].
The reaction was carried out in ethanol–water at reflux temp-
eratures for 5–6 hours, whereupon all the DMSO and chlorido
ligands were replaced by the free ‘2,2′-bpy’ entities of Rubbn-
mono complexes. All the inert complexes (tri, tetra, tetra-nl
species) were purified by cation exchange on an SP Sephadex
C-25 column, whereas the chlorido-containing complexes
(Rubbn-Cl2) were purified by size exclusion on an Sephadex
LH-20 column.
It is noted that geometric isomers will exist for the oligo-
nuclear complexes in this study. In the bridging ligands bbn,
the 2,2′-bipyridine coordinating moieties are unsymmetrically
substituted – one pyridine entity with a methyl group in the
4-position and the other with the bridging methylene chain.
Accordingly, for cases where there are two bbn ligands attached
to one metal centre – as is the case for the central ruthenium
in the trinuclear complexes and the two central ruthenium
centres in the linear tetranuclear species – the chain-bearing
pyridine entities may bear either relative ‘trans’ or one of two
possible ‘cis’ orientations (one symmetrical in the sense that
the centre will have C2 point group symmetry – denoted s-cis –
and the other has C1 point group symmetry – denoted u-cis).
For the trinuclear case (Rubbn-tri) there are three isomers possi-
ble based on the central metal centre (trans, s-cis and u-cis),
and six isomers based on the two internal metal centres (trans,
trans; s-cis,s-cis; u-cis,u-cis; trans,s-cis; trans,u-cis; s-cis,u-cis) for
the linear tetranuclear case (Rubbn-tetra). For the dinuclear
Rubbn-Cl2 complexes the two chlorido ligands may bear either
a cis,cis or a cis,trans relationship to the chain-bearing pyridine
entity, so that there are two isomers. Finally, in the case of the
non-linear tetranuclear complexes, Rubbn-tetra-nl, the central
Ru centre has three bbn ligands attached so that the chain-
bearing pyridine entities may bear either a facial or meridional
orientation to one another – giving rise to two isomers ( fac
and mer). In the case of fac/mer geometric isomerism, the mer
isomer is thermodynamically preferred for statistical reasons
(3/1) but the mer/fac ratio is often considerably greater than
that because of steric congestion in the fac form.34 In the
present case for the tetra-nl species, 2D NMR studies (COSY
and ROESY – not reported) indicated the existence of both
isomers with the fac isomer comprising about 5% (mer/fac =
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19/1). The separation of possible geometrical isomers was not
attempted for any of the complex systems in this study at this
stage, and would represent a significant challenge in a
number of these cases.
In agreement with previous studies, the Rubbn-Cl2 com-
plexes hydrolysed when they were dissolved in water.35,36 The
aromatic region of the 1H NMR spectrum of a Rubbn-Cl2
complex dissolved in water was extremely complicated
suggesting a mixture of [Rubbn(OH2)Cl]
+ and [Rubbn(OH2)2]
2+
species, as has been previously observed for the hydrolysis of
cis-[Ru(bpy)2Cl2].
36 Consistent with this proposal, the addition
of AgNO3 to a Rubbn-Cl2 complex that had been in an aqueous
solution for two days did induce some changes in the NMR
spectrum. However, even after the addition of AgNO3, the aro-
matic region in the NMR spectrum was still very complex. This
could indicate that both the cis- and trans-diaqua species were
formed, as has been noted in the acid hydrolysis of [Ru(CO3)-
(bpy)2].
37
Electrochemistry
Cyclic voltammetry was used to determine the redox potentials
for the multinuclear complexes with n = 12 (Table 1). All com-
plexes showed a single, reversible Ru(II/III) oxidation peak at
≈+1.27 V vs. Ag/AgCl, and a series of ligand-based reductions,
consistent with the well-established behaviour of tris(biden-
tate) polypyridylruthenium complexes.38,39 It was thought that
differences might be discernible in the potentials, particularly
the reduction patterns, given the subtle structural variations in
the different metal centres in the multinuclear complexes.
For example it has been established that in the homoleptic
Fig. 1 Chlorido-containing dinuclear complexes (Rubbn-Cl2); and the inert trinuclear (Rubbn-tri) and tetranuclear (linear Rubbn-tetra, and non-
linear Rubbn-tetra-nl) ruthenium(II) complexes.
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Scheme 1
Scheme 2
Paper Dalton Transactions
16716 | Dalton Trans., 2014, 43, 16713–16725 This journal is © The Royal Society of Chemistry 2014
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
1 
O
ct
ob
er
 2
01
4.
 D
ow
nl
oa
de
d 
on
 0
9/
03
/2
01
5 
00
:0
6:
26
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
complexes [Ru(phen)3]
2+ and [Ru(Me2bpy)3]
2+, the Me2bpy
ligand is slightly more difficult to reduce than phen due to the
electron-donating effect of the methyl groups, and this also
translates to an effect on the Ru(II) centre, which undergoes
oxidation more readily.39,40 Either terminal of the bb12 ligand
could be expected to mimic a Me2bpy ligand, as has been
observed for the complex [{(bpy)2Ru}2(bb2)]
4+, which shows
very similar redox potentials to the mononuclear complex [Ru-
(bpy)2(Me2bpy)]
2+.41 In the present case, no significant differ-
ences were observed in the oxidation potentials of the com-
plexes, even for the non-linear tetranuclear complex, in which
the central ruthenium differs somewhat more from the others.
The reduction patterns were also quite similar, with each
complex showing two closely-spaced reductions. A third clear
reduction peak was observed for Rubb12, though this was dis-
torted by adsorption. This three-reduction set is consistent
with the pattern reported for both mononuclear [Ru(L)2-
(Me2bpy)]
2+ (L = bpy, phen) and dinuclear [{Ru(bpy)2}2}(bbn)]
4+
(n = 2,3).41–43 For the tri- and tetra-nuclear complexes only a
small peak was evident at potentials where a third reduction
might be expected, and a desorption peak was generally
observed in the re-oxidation scan. Adsorption of reduction pro-
ducts has previously been noted for other multinuclear ruthe-
nium bipyridyl complexes.44,45 The results indicate that redox
differences between the complexes are negligible and unlikely
to underpin any differences in biological activity.
Antimicrobial activity
The minimum inhibitory concentrations (MIC) for the di-, tri-
and tetra-nuclear ruthenium complexes against four bacterial
strains {Staphylococcus aureus (S. aureus), methicillin-resistant
S. aureus (MRSA), Escherichia coli (E. coli) and Pseudomonas
aeruginosa (P. aeruginosa)} have been determined and the
results are summarised in Table 2. The results demonstrate
that some of the ruthenium(II) complexes in the present study
have significant antimicrobial activity against both classes of
bacteria, and most of the complexes are more active against
Gram positive bacteria than the Gram negative strains. Of par-
ticular note, the inert tri- and tetra-nuclear ruthenium com-
plexes showed better antimicrobial activity than the
corresponding dinuclear ruthenium(II) complexes (Rubbn),
particularly when the MIC values are given on a molar basis.
Interestingly, the non-linear tetranuclear ruthenium(II) com-
plexes (Rubbn-tetra-nl) were two-fold less active than the dinuc-
lear Rubbn complexes. Of all the complexes, Rubb12-tri,
Rubb16-tri, Rubb12-tetra and Rubb16-tetra are the most active
compounds, and are up to four-times more active than the
dinuclear counterparts against Gram positive and slightly
more active against the Gram negative strains. Furthermore,
Rubb12-tri, Rubb16-tri, Rubb12-tetra and Rubb16-tetra are 4–8
times more active than the previously reported Rubb7-tri and
Rubb7-tetra complexes.
13 Even though the overall charge of the
linear and non-linear version of the tetranuclear complexes is
the same (8+), the non-linear tetranuclear ruthenium com-
plexes (Rubbn-tetra-nl) are less active when compared to the
corresponding linear species, suggesting that the linearity
could play an important role in inhibiting bacterial growth. The
dinuclear ruthenium(II) complexes with two chlorido ligands
(Rubbn-Cl2) also showed good activity, but are fractionally less
active than the tri- and tetra-nuclear complexes. In general,
complexes with the bb12 linking ligand were the most active
against S. aureus, MRSA, and E. coli, with the complexes
having the shortest (bb10) and longest (bb16) linking chain
being the least active. However, against P. aeruginosa, com-
plexes with the bb16 linking ligand showed better activity.
Due to their greater lipophilicity (see below), it was con-
sidered that the antimicrobial activity of the tri- and tetra-
nuclear complexes could decrease to a greater extent with
longer incubation times than would the dinuclear complexes.
Table 3 summarises the MIC values for the ruthenium com-
plexes when the assays were carried out over a 20–22 hour
timeframe. The MIC values for the tri- and tetra-nuclear com-
plexes increased by as much as four-fold for some of the com-
plexes when compared to the 16–18 hour values. Alternatively,
the dinuclear complexes Rubb12 and Rubb16 only exhibited a
maximum two-fold decrease in activity across the four bacteria.
These observations suggest that the tri- and tetra-nuclear com-
plexes rapidly accumulate within the bacteria, thereby decreas-
ing the concentration in the incubation broth. However, even
Table 1 Electrode potentials for Ru(II) complexes in CH3CN (in V vs.
Ag/AgCl)
Complex
Oxidation
{E1/2 Ru(II/III)} Reductions (Epc)
a
Rubb12 1.26 −1.33, −1.52, −1.92
Rubb12-tri 1.28 −1.32, −1.49, −1.85b
Rubb12-tetra 1.26 −1.33, −1.50, −1.84b
Rubb12-tetra-nl 1.27 −1.32, −1.49, −1.85b
a Irreversible/semi-reversible; cathodic peak given. bWeak.
Table 2 MIC values (µM) for the ruthenium complexes after
16–18 hours of incubation against Gram positive and Gram negative
bacterial strains
Compounds
Gram positive Gram negative
S. aureus MRSA E. coli P. aeruginosa
Rubb12 0.6 0.6 2.5 20.1
Rubb16 1.2 1.2 2.4 9.8
Rubb10-tri 0.8 1.7 1.7 13.5
Rubb12-tri 0.4 0.8 1.6 13.1
Rubb16-tri 0.4 0.8 3.1 12.6
Rubb10-tetra 1.2 2.5 2.5 19.9
Rubb12-tetra 0.3 0.6 1.2 9.7
Rubb16-tetra 0.3 0.6 2.3 9.2
Rubb10-tetra-nl 2.5 2.5 5.0 19.9
Rubb12-tetra-nl 1.2 1.2 4.9 19.4
Rubb16-tetra-nl 1.1 2.3 4.6 18.5
Rubb10-Cl2 5.9 5.9 5.9 46.9
Rubb12-Cl2 1.4 1.4 2.9 23.0
Rubb16-Cl2 1.4 2.8 5.5 44.2
Ampicillin <0.7 183.0 11.4 > 366.0
Gentamicin <0.5 66.9 1.0 0.5
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at the longer incubation time Rubb12-tetra and Rubb16-tetra
are the most active of all the ruthenium complexes tested.
The minimum bactericidal concentrations (MBC) of a selec-
tion of the ruthenium complexes were determined after the
MIC values were obtained for the 20–22 hour incubation
experiment. The results are summarised in Table 4. As the
MBC values are generally ≤2 × MIC for the 20–22 hour incu-
bation, it can be concluded that the tri- and tetra-nuclear com-
plexes are bactericidal rather than bacteriostatic.
Log P
Lipophilicity is a significant factor that affects the biological
activity of any metal complex, as it is generally correlated to
the capacity of the drug to penetrate through the cell mem-
brane. The standard octanol-water partition coefficient (log P)
was determined for the mononuclear species [Ru(phen)2-
(Me2bpy)]
2+ and Rubbn (as control experiments), Rubbn-tri,
Rubbn-tetra and Rubbn-tetra-nl complexes, and the results are
summarised in Table 5. From the results, the trinuclear ruthe-
nium complexes are more lipophilic than the tetranuclear
ruthenium complexes. For the dinuclear Rubbn complexes, the
antimicrobial activity was directly related to the log P, with
activity increasing with increasing lipophilicity. However,
although the trinuclear complexes were more lipophilic than
their corresponding linear tetranuclear complexes, they were
less active. This suggests lipophilicity is an important determi-
nant of activity, but only to the level that allows the ruthenium
complex to easily diffuse across the cellular membrane.
Cellular accumulation
The cellular accumulations of the tri- and tetra-nuclear ruthe-
nium complexes in S. aureus, MRSA, E. coli, and P. aeruginosa
were determined by measuring the concentration of the
complex remaining in the culture supernatant after removing
the bacteria by centrifugation. The concentration of the ruthe-
nium complex in the supernatant was calculated from an
absorbance calibration curve obtained by adding known con-
centrations of the ruthenium complex to a blank supernatant.
As the absorbance of the ruthenium complexes varied with the
different broths and supernatants for each bacterial strain, a
calibration curve was determined for each complex in the
supernatant of each bacterial strain. The uptake of complexes
into bacterial strains was measured at various incubation time
points, however the uptake did not significantly change with
incubation time after 30 minutes. Fig. 2 shows the uptake of
the ruthenium complexes into the bacteria after 30 minutes.
Surprisingly, the uptake of the complexes is slightly higher for
the Gram negative bacteria than the Gram positive. The
Table 3 MIC values (µM) for the ruthenium complexes after
20–22 hours of incubation against Gram positive and Gram negative
bacterial strains
Compound
Gram positive Gram negative
S. aureus MRSA E. coli P. aeruginosa
Rubb12 1.3 2.5 5.0 40.3
Rubb16 1.2 2.4 4.9 19.6
Rubb10-tri 1.7 3.4 3.4 27.0
Rubb12-tri 1.6 1.6 3.3 26.3
Rubb16-tri 1.6 1.6 6.3 25.1
Rubb10-tetra 2.5 5.0 5.0 19.9
Rubb12-tetra 0.6 1.2 2.4 9.7
Rubb16-tetra 1.1 1.1 2.3 9.2
Rubb10-tetra-nl 5.0 5.0 9.9 19.9
Rubb12-tetra-nl 1.2 2.4 4.9 19.4
Rubb16-tetra-nl 2.3 2.3 4.6 18.5
Rubb10-Cl2 5.9 11.7 5.9 46.9
Rubb12-Cl2 2.9 1.4 5.7 23.0
Rubb16-Cl2 2.8 2.8 11.0 44.2
Ampicillin <0.7 183.0 11.4 >366.0
Gentamicin <0.5 66.9 1.0 0.5
Table 4 MBC values (µM) for a selection of the ruthenium complexes
against Gram positive and Gram negative bacterial strains
Compound
Gram positive Gram negative
S. aureus MRSA E. coli P. aeruginosa
Rubb12 2.6 2.5 10.1 40.3
Rubb12-tri 3.3 3.3 6.6 52.6
Rubb16-tri 1.6 6.3 12.6 50.3
Rubb12-tetra 1.2 1.2 2.4 19.4
Rubb16-tetra 2.3 2.3 4.6 37.0
Table 5 Octanol–water partition coefficients (log P) for the ruthenium
complexes
Metal complex Charge log P
[Ru(phen)2(Me2bpy)]
2+ +2 −2.9
Rubb12 +4 −2.9
Rubb16 +4 −1.9
Rubb10-tri +6 −1.3
Rubb12-tri +6 −1.0
Rubb16-tri +6 −0.8
Rubb10-tetra +8 −1.7
Rubb12-tetra +8 −1.6
Rubb16-tetra +8 −0.95
Rubb10-tetra-nl +8 −1.9
Rubb12-tetra-nl +8 −1.4
Rubb16-tetra-nl +8 −1.1
Fig. 2 Cellular uptake of the ruthenium complexes into four bacteria
after a 30 minute incubation.
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accumulation of Rubb16-tri was the highest in both Gram posi-
tive and Gram negative bacteria. For all the complexes lower
levels of accumulation were observed for S. aureus, compared
to the other bacteria. For both the Gram positive and Gram
negative bacteria, the cellular accumulation of the tetranuclear
metal complexes was slightly lower than with the trinuclear
counterparts. Surprisingly, the uptake of Rubb12-tetra-nl is
greater than Rubb12-tetra and Rubb12-tri.
Discussion
We have previously shown that dinuclear ruthenium(II) com-
plexes (Rubbn) exhibit excellent antimicrobial properties in
terms of MIC values, cellular uptake, time-kill curves and show
low toxicity towards human cells.13 In order to further improve
the antimicrobial properties, we have synthesised the tri- and
tetra-nuclear ruthenium(II) analogues of the most active dinuc-
lear complexes, Rubb12 and Rubb16, and examined their in
vitro susceptibility, lipophilicity and cellular accumulation.
The results of the MIC assays indicate that the linear tetranuc-
lear complexes, Rubbn-tetra, are consistently more active
across the four bacteria used in this study than Rubb12 and
Rubb16. Alternatively, the trinuclear analogues of Rubb12 and
Rubb16 are slightly more active against some bacteria than the
corresponding dinuclear complexes, but slightly less active in
others. In a similar manner to Rubb12 and Rubb16, the tri- and
tetra-nuclear linear complexes maintain their activity against
MRSA compared to S. aureus, and are bactericidal. The non-
linear tetranuclear complexes, Rubbn-tetra-nl, are consistently
less active than their linear counterparts and Rubb12 and
Rubb16. Significantly, whereas Rubb10-tri was generally more
active than Rubb10-tetra, the activity of Rubbn-tetra was greater
than Rubbn-tri for n = 12 and 16 over the four bacterial strains
used in the study.
The lipophilicity of the ruthenium complexes, as deter-
mined by log P, increased in the order Rubbn < Rubbn-tetra <
Rubbn-tri, with all tri- and tetra-nuclear complexes being sig-
nificantly more lipophilic than Rubb16. As the ruthenium com-
plexes enter bacterial cells by passive diffusion,46 it is not
surprising that the cellular accumulation experiments demon-
strated that the tri- and tetra-nuclear complexes rapidly
accumulate to high concentrations within the bacteria.
However, the extent of the cellular accumulation of the tri- and
tetra-nuclear complexes in the Gram negative bacteria, particu-
larly P. aeruginosa, is surprising. The results of this study
demonstrate that the lower toxicity of the dinuclear complexes
towards P. aeruginosa is probably not strongly correlated to the
cellular accumulation – as we previously concluded – but
rather to a lower intrinsic ability to kill P. aeruginosa cells. Pre-
liminary pharmacokinetic experiments with mice have indi-
cated that Rubb12 and Rubb16 are rapidly cleared from the
blood;47 consequently, the greater lipophilicity and greater cel-
lular uptake may be advantageous for in vivo antimicrobial
studies.
Interestingly, the one non-linear tetranuclear complex
examined in cellular accumulation experiments, Rubb12-tetra-
nl, showed greater accumulation than the corresponding
linear complex Rubb12-tetra. Despite Rubb12-tetra-nl being
slightly more lipophilic than Rubb12-tetra, it would be
expected that the linear complex would cross a cell membrane
more easily than a non-linear complex. However, as the ruthe-
nium complexes enter bacterial cells by passive diffusion,47
the level of the cellular accumulation is a function of the
binding of the ruthenium complex to intra-cellular receptors,
such as nucleic acids and proteins. Despite the relatively
greater accumulation of Rubb12-tetra-nl compared to Rubb12-
tetra, the linear complex exhibited greater activity. Previous
studies have shown that because of the flexibility of the alkane
chain in the bbn ligand, both ruthenium metal centres in the
Rubbn complexes can closely associate with the DNA minor
groove.48 Similarly, the linear tetranuclear complexes could
also follow the curvature of the DNA groove allowing close
association of the four ruthenium centres with the DNA back-
bone. Alternatively, due to the three-dimensional shape of the
non-linear tetranuclear complexes, the interactions with DNA
would be substantially different and a different biological
response would be expected.
There has been increasing interest in trinuclear and higher
nuclearity ruthenium complexes as anticancer agents.28–30
However, there have been very few studies on the potential of
tri- or tetra-nuclear ruthenium complexes as antimicrobial
agents. The present study indicates that these multinuclear
complexes are highly active antimicrobial agents. Conse-
quently, using the Rubbn scaffold as a starting point, oligonuc-
lear ruthenium complexes can be synthesised which vary by
almost two orders of magnitude in lipophilicity, but contain a
higher charge and remain water-soluble. Furthermore, the
higher nuclearity complexes would be expected to display
different nucleic acid binding or condensation potential and
exhibit different pharmacokinetic profiles. Given the rapid
uptake and high level of accumulation of the tetranuclear com-
plexes in bacteria, it is unlikely that pentanuclear or higher
nuclearity complexes would be more effective antimicrobial
agents.
Experimental
Physical measurements
1H NMR and 13C NMR spectra were recorded on a Varian
Advance 400 MHz spectrometer at room temperature in D2O
{99.9%, Cambridge Isotope Laboratories (CIL)}, CDCl3 (99.8%,
CIL), or CD3CN (>99.8%, Aldrich), or CD3OD (>99.8%,
Aldrich). UV absorbance was measured on a Jenway 6300 spec-
trophotometer. Microanalyses were performed by the Micro-
analytical Unit, Research School of Chemistry, Australian
National University, Canberra. High-resolution mass spectral
measurements were made using a Waters LCT mass spectro-
meter (Research School of Chemistry, Australian National
University).
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Materials and methods
Tetraethylammonium chloride, 2-methoxyethanol, lithium
chloride, potassium hexafluorophosphate (KPF6) and
ammonium hexafluorophosphate (NH4PF6) were purchased
from Aldrich and used as supplied; Amberlite® IRA-402 (chlor-
ide form) anion-exchange resin, SP-Sephadex C-25 cation
exchanger and Sephadex® LH-20 were obtained from GE
Health Care Bioscience. Cation-adjusted Mueller-Hinton broth
(CAMHB) was purchased from Fluka, Gillingham, UK; the
control antibiotics gentamicin and ampicillin were purchased
from Oxoid, Australia. The syntheses of ligands bbn (n = 10, 12
and 16) and [Ru(phen)2(py)2]Cl2, (phenH
+)[Ru(phen)Cl4], cis-
[Ru(DMSO)4Cl2] were performed according to reported litera-
ture methods.33,49–51
Bacterial strains
All bacterial strains are classified as C2 risk group and must be
handled within a PC2 laboratory. Two Staphylococcus aureus
(Gram positive) isolates, a methicillin-susceptible S. aureus
strain (ATCC 25923), a clinical multidrug-resistant MRSA strain
(a wild clinical strain from the JCU culture collection) and two
Gram negative isolates Escherichia coli (ATCC 25922) and
Pseudomonas aeruginosa (ATCC 27853) were used for in vitro
antimicrobial studies.
MIC and MBC determination
The MIC tests were conducted by the broth micro-dilution
method in duplicate as outlined in the CLSI guidelines.52 The
MBC tests were performed in duplicate according to the stan-
dard microbiological techniques protocol.53 The bacteria were
grown on Mueller-Hinton agar and suspended in growth
medium CAMHB. Bacterial inocula were adjusted to a turbidity
equivalent to that of a 0.5 McFarland standard and diluted to
a final concentration of 4–8 × 105 cfu mL−1. Compounds tested
were dissolved and serially diluted in cation-adjusted Mueller–
Hinton broth (CAMHB; Fluka, Gillingham, UK) in sterile
96-well flat-bottom plates to a final volume of 100 µL in each
well. An equal volume of inocula was added to each well,
making a final concentration range of the compounds tested,
including the control antibiotics gentamicin and ampicillin
(Oxoid, Australia), of between 0.25 and 128 mg L−1. MICs were
recorded after 16–18 h and 20–22 h of incubation at 37 °C.
Colony counts of the inocula were performed for determi-
nation of the MBC. After MIC results were noted, the incu-
bation was continued for another 4 h, the wells with no visible
growth were taken into colony counting and the concentration
of compounds that produced a 99.9% kill relative to the start-
ing inoculum was recorded as the MBC.
Cellular uptake
The cellular uptake of the ruthenium complexes was measured
by monitoring the UV absorbance of the complexes remaining
in the supernatant of the cultures after incubation for various
periods of time. Bacterial inocula in log phase were adjusted
to a cell concentration from 1–5 × 107 cfu mL−1. Aliquots
(2 mL) of the adjusted inocula were placed in glass culture
tubes and 50 µL of stock solution (330 mg L−1) of the ruthe-
nium complex was added to give a final concentration of 8 mg
L−1. Control flasks containing 50 mL of each bacterial suspen-
sion were set up as blank samples to obtain UV calibration
curves for each complex. Culture tubes and control flasks were
incubated with agitation at 150 rpm at 37 °C for 0.5, 1, 1.5 or
2 h. At the end of incubation, the culture tubes were centri-
fuged (S. aureus and MRSA at 6000g; E. coli and P. aeruginosa
at 17 000g) at 4 °C for 10 min. Supernatants (1.6 mL) were care-
fully transferred to 2 mL tubes and the UV absorbance of the
remaining ruthenium complex was measured at λ = 488 nm.
Volumes (10, 30, 40, 50 and 65 µL) of a stock solution (330 mg
L−1) of each complex were added to 2 mL aliquots of the super-
natant from each control bacterial suspension (untreated with
drug) to acquire a UV-concentration linear correlation chart for
calibration. The uptake of the complexes was calculated by
using the calibration curve obtained from control bacterial
aliquots.
Lipophilicity (log P) determination
The partition coefficients (log P) were measured using the
shake-flask technique: each ruthenium complex (at 0.1 mM)
was dissolved in the water phase and an equal volume of
n-octanol was added. The two phases were mutually saturated
by shaking overnight at ambient temperature and then were
allowed to separate on standing. The concentration of the
metal complex in each phase was determined spectrophoto-
metrically at λ = 450 nm.
Electrochemistry
Cyclic voltammetry was carried out using an eDAQ EA161
potentiostat operated via an eDAQ ED401 e-corder. A glassy
carbon working electrode, platinum wire counter electrode
and Ag/AgCl reference electrode were used. Ferrocene was used
as an internal reference check.54 HPLC grade acetonitrile was
used as solvent and the supporting electrolyte was 0.1 M tetra-
n-butylammonium tetrafluoroborate.
Synthesis of metal complexes
[Ru(phen)2(bbn)](PF6)2 (Rubbn-mono). The mononuclear
ruthenium(II) complexes Rubbn-mono were synthesised as pre-
viously described (n = 7 and 16),33 with typical yields being
50–60%. The 1H NMR spectrum of Rubb16-mono was consist-
ent with that previously reported.33 [Ru(phen)2(bb12)]-
(PF6)2·2H2O Anal. Calcd for C58H62N8F12O2P2Ru: C, 53.8%; H,
4.83%; N, 8.7%. Found: C, 53.9%; H, 4.80%; N, 8.5%. 1H NMR
(400 MHz, CD3CN): δ 8.63 (d, J = 8.0 Hz, 2H); 8.52 (dd, J =
8.2 Hz, 3.3 Hz, 2H); 8.40 (s, 2H); 8.35 (s, 2H); 8.26–8.17 (m,
8H); 7.88–7.85 (m, 2H); 7.78 (dd, J = 8.1 Hz, 5.1 Hz, 2H);
7.56–7.51 (m, 2H); 7.50–7.46 (m, 2H); 7.22–7.17 (m, 2H); 7.10
(t, J = 9.0 Hz, 2H); 2.76 (t, J = 7.6 Hz, 2H); 2.67 (t, J = 7.2 Hz,
2H); 2.51 (s, 3H); 2.41 (s, 3H); 1.70–1.56 (m, 4H); 1.35–1.17
(m, 16H). [Ru(phen)2(bb10)](PF6)2·3H2O Anal. Calcd for
C56H60N8F12O3P2Ru: C, 52.4%; H, 4.71%; N, 8.7%. Found: C,
52.2%; H, 4.47%; N, 8.5%. 1H NMR (400 MHz, CD3CN): δ 8.63
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(d, J = 8.0 Hz, 2H); 8.48 (dd, J = 10.6 Hz, 4.7 Hz, 2H); 8.40 (s,
2H); 8.35 (s, 2H); 8.27–8.16 (m, 8H); 7.87 (d, J = 4.8 Hz, 2H);
7.81–7.75 (m, 2H); 7.57–7.51 (m, 2H); 7.48 (t, J = 6.4 Hz, 2H);
7.22–7.17 (m, 2H); 7.12–7.08 (m, 2H); 2.76 (t, J = 7.4 Hz, 2H);
2.68 (t, J = 7.5 Hz, 2H); 2.50 (s, 3H); 2.41 (s, 3H); 1.70–1.59 (m,
4H); 1.36–1.24 (m, 12H).
[{Ru(phen)2}(µ-bbn){Ru(phen)Cl2}]Cl2 (Rubbn-Cl2). [Ru(phen)2-
(bb12)](PF6)2 (450 mg, 0.35 mmol), (phenH
+)[Ru(phen)Cl4]
(216 mg, 0.35 mmol) and lithium chloride (280 mg) were dis-
solved in dry DMF (28 mL) and the mixture was stirred at
150 °C for 8 h in the dark under a nitrogen atmosphere. After
cooling the reaction mixture to room temperature, acetone
(80 ml) was added and the product precipitated as a dark
brown material, which was kept with the mother liquor in the
fridge for 16 h. The precipitate was then filtered and washed
with acetone (40 mL), dried under vacuo and redissolved in
ethanol (20 mL). Solid NH4PF6 (200 mg) was added to the
ethanol solution, resulting in the precipitation of the PF6
− salt
of the complex, which was then filtered and washed with
ethanol (2 × 20 mL) and diethyl ether (2 × 20 mL) to afford a
dark brown solid. The complex was purified on a Sephadex
LH-20 column (2 cm diam. × 30 cm) using acetone as the
eluent. The major first band (brown) was collected and
acetone was evaporated to obtain [{Ru(phen)2}(µ-bb12)-
{Ru(phen)Cl2}](PF6)2 as dark brown solid. The sample was
transferred to a drying tube by dissolution in dichloro-
methane, which was removed in vacuo and the residue used
for characterisation. [{Ru(phen)2}(µ-bb12){Ru(phen)Cl2}](PF6)2·
0.5NH4PF6. Anal. Calcd for C70H68N10.5Cl2F15P2.5Ru2: C,
49.7%; H, 4.05%; N, 8.7%. Found: C, 49.6%; H, 3.67%; N,
8.3%. 1H NMR (400 MHz, CD3CN): δ 8.64 (d, J = 8.1 Hz, 4H);
8.54 (d, J = 8.3 Hz, 4H); 8.41–8.34 (m, 2H); 8.28–8.22 (m, 4H);
8.21–8.17 (m, 4H); 7.89–7.85 (m, 4H); 7.81–7.76 (m, 2H); 7.55
(dd, J = 7.8 Hz, 5.1 Hz, 4H); 7.48 (t, J = 5.0 Hz, 4H); 7.13–7.08
(m, 4H); 2.79–2.72 (m, 4H); 2.52 (s, 6H); 1.70–1.58 (m, 4H);
1.39–1.20 (m, 16H).
[{Ru(phen)2}(µ-bb16){Ru(phen)Cl2}](PF6)2 and [{Ru(phen)2}-
(µ-bb10){Ru(phen)Cl2}](PF6)2 complexes were synthesised as
reported above for [{Ru(phen)2}(µ-bb12){Ru(phen)Cl2}](PF6)2.
[{Ru(phen)2}(µ-bb16){Ru(phen)Cl2}](PF6)2·3CH2Cl2·C3H6O. Anal.
Calcd for C80H86N10Cl8F12OP2Ru2: C, 48.5%; H, 4.38%; N,
7.1%. Found: C, 48.2%; H, 4.66%; N, 6.7%. 1H NMR
(400 MHz, CD3CN): δ 8.64 (d, J = 8.1 Hz, 4H); 8.53 (d, J = 7.9
Hz, 4H); 8.42–8.34 (m, 2H); 8.27–8.22 (m, 4H); 8.21–8.16 (m,
4H); 7.89–7.85 (m, 4H); 7.79 (dd, J = 7.9 Hz, 5.0 Hz, 2H); 7.55
(dd, J = 8.0 Hz, 5.1 Hz, 4H); 7.48 (t, J = 5.2 Hz, 4H); 7.13–7.08
(m, 4H); 2.79–2.73 (m, 4H); 2.51 (s, 6H); 1.69–1.60 (m, 4H);
1.39–1.19(m, 24H). [{Ru(phen)2}(µ-bb10){Ru(phen)Cl2}](PF6)2·
NH4PF6·2CH2Cl2. Anal. Calcd for C70H70N11Cl6F18P3Ru2:
C, 43.9%; H, 3.68%; N, 8.1%. Found: C, 43.8%; H, 3.54%;
N, 7.9%. 1H NMR (400 MHz, CD3CN): δ 8.65 (d, J = 7.9 Hz, 4H);
8.54 (d, J = 7.7 Hz, 4H); 8.42–8.34 (m, 2H); 8.28–8.16 (m, 8H);
7.90–7.84 (m, 4H); 7.82–7.75 (m, 2H); 7.55 (dd, J = 8.3 Hz,
5.3 Hz, 4H); 7.48 (t, J = 5.1 Hz, 4H); 7.14–7.07 (m, 4H);
2.80–2.72 (m, 4H); 2.51 (s, 6H); 1.72–1.58 (m, 4H); 1.42–1.21
(m, 12H).
The PF6
− salts were converted to chloride salts with Amber-
lite IRA-402 (chloride form) anion-exchange resin. The PF6
−
salt of the complex was taken up in methanol (25 mL) and
resin added and the mixture stirred at room temperature for
1–2 h until the solution was clear, the resin was then filtered
and methanol was evaporated and the resultant solid dried in
an oven at 70 °C for 16 h to obtain a dark brownish-orange
solid of [{Ru(phen)2}(µ-bbn){Ru(phen)Cl2}]Cl2 (Rubbn-Cl2),
typical yields were 60–65%, based on the synthetic starting
material [Ru(phen)2(bbn)](PF6)2.
[{Ru(phen)2}(µ-bbn){Ru(phen)}(µ-bbn){Ru(phen)2}]Cl6 (Rubbn-
tri). In a typical reaction, both the starting materials [{Ru-
(phen)2}(µ-bb16){Ru(phen)Cl2}](PF6)2 (125 mg, 0.075 mmol)
and [Ru(phen)2(bb16)](PF6)2 (98 mg, 0.075 mmol) were dis-
solved in ethanol–water (1 : 1, 60 mL) and the mixture refluxed
at 80 °C in the dark under a nitrogen atmosphere for 4 h. The
colour of the reaction mixture slowly turned from dark brown
to dark red during the course of the reaction. The reaction
mixture was cooled to room temperature and the solvent was
evaporated under reduced pressure to obtain a dark orange
solid, the resulting solid was converted to chloride salt by stir-
ring it in methanol using Amberlite IRA-402 (chloride form)
anion-exchange resin for 1–2 h, after filtration of the resin,
methanol was evaporated and the resultant chloride salt was
dissolved in water (10 mL) and loaded onto an SP Sephadex
C-25 cation exchange column (2 cm diam. × 25 cm), the
column was washed with water and eluted with 0.6 M and
then 0.8 M NaCl solutions to remove mono- and di-nuclear
impurities. The desired trinuclear complex was eluted with
1 M NaCl solution containing 20% acetone. After removing the
acetone, solid KPF6 was added to the eluate and the complex
was extracted into dichloromethane (2 × 30 mL). The organic
layer was washed with water (20 mL), dried over anhydrous
Na2SO4, and evaporated to dryness to obtain PF6
− salt of the
complex. The complex was further purified on Sephadex LH-20
(2 cm diam. × 30 cm) using acetone as the eluent. The major
first orange band was collected and the acetone removed and
the product crystallised using acetonitrile–toluene to obtain a
bright red-orange solid of [{Ru(phen)2}(µ-bb16){Ru(phen)}-
(µ-bb16){Ru(phen)2}](PF6)6. [{Ru(phen)2}(µ-bb16){Ru(phen)}-
(µ-bb16){Ru(phen)2}](PF6)6. Anal. Calcd for C136H140N18F36P6Ru3:
C, 51.0%; H, 4.41%; N, 7.9%. Found: C, 51.2%; H, 4.29%; N,
7.8%. 1H NMR (400 MHz, CD3CN): δ 8.67–8.60 (m, 5H);
8.57–8.49 (m, 5H); 8.43–8.34 (m, 8H); 8.29–8.17 (m, 18H);
7.88 (m, 5H); 7.82–7.76 (m, 5H); 7.59–7.51 (m, 8H); 7.48
(m, 5H); 7.14–7.07 (m, 5H); 2.82–2.72 (m, 8H); 2.57 (s, 3H);
2.51 (s, 6H); 2.47 (s, 3H); 1.72–1.59 (m, 8H); 1.39–1.17 (m,
48H). 13C NMR (CD3CN): δ 157.82, 157.76, 157.5, 155.7, 155.4,
153.57, 153.53, 153.48, 152.3, 152.1, 151.2, 148.8,
148.6, 137.55, 137.42, 131.9, 129.0, 128.9, 128.2, 126.86,
126.76, 125.7, 124.9, 35.6, 30.8, 30.4, 30.3, 30.2, 30.0, 29.9,
28.7, 21.4 and 21.0. TOF MS (ESI+): most abundant ion
found for [M − 4PF6]4+, m/z 654.94. Calc. for Ru3[C136H140N18]-
(PF6)2
4+, m/z 654.97; most abundant ion found
for [M − 3PF6]3+, m/z 921.59. Calc. for Ru3[C136H140N18]-
(PF6)3
3+, m/z 921.61; most abundant ion found for
Dalton Transactions Paper
This journal is © The Royal Society of Chemistry 2014 Dalton Trans., 2014, 43, 16713–16725 | 16721
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
1 
O
ct
ob
er
 2
01
4.
 D
ow
nl
oa
de
d 
on
 0
9/
03
/2
01
5 
00
:0
6:
26
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
[M − 2PF6]2+, m/z 1454.87. Calc. for Ru3[C136H140N18](PF6)42+,
m/z 1454.90.
[{Ru(phen)2}(µ-bb12){Ru(phen)}(µ-bb12){Ru(phen)2}](PF6)6.
Anal. Calcd for C128H124N18F36P6Ru3: C, 49.8%; H, 4.05%; N,
8.2%. Found: C, 50.1%; H, 3.82%; N, 8.2%. 1H NMR
(400 MHz, CD3CN): δ 8.66–8.61 (m, 5H); 8.56–8.50 (m, 5H);
8.42–8.34 (m, 8H); 8.28–8.16 (m, 18H); 7.91–7.85 (m, 5H);
7.81–7.76 (m, 5H); 7.58–7.52 (m, 8H); 7.50–7.45 (m, 5H);
7.13–7.08 (m, 5H); 2.81–2.71 (m, 8H); 2.57 (s, 3H); 2.51 (s, 6H);
2.47 (s, 3H); 1.71–1.59 (m, 8H); 1.41–1.17 (m, 32H). 13C NMR
(CD3CN): δ 157.8, 157.7, 157.5, 155.8, 154.9, 153.6, 153.5,
153.3, 152.3, 152.1, 151.2, 148.8, 148.5, 137.5, 137.4, 131.8,
129.0, 128.9, 128.4, 126.8, 126.7, 125.7, 124.9, 35.6, 30.9, 30.7,
30.4, 30.2, 30.1, 30.0, 29.8, 28.9, 21.1 and 20.8. TOF MS (ESI+):
most abundant ion found for [M − 4PF6]4+, m/z 626.91. Calc.
for Ru3[C128H124N18](PF6)2
4+, m/z 626.91; most abundant ion
found for [M − 3PF6]3+, m/z 884.21. Calc. for Ru3[C128H124N18]-
(PF6)3
3+, m/z 884.21; most abundant ion found for [M −
2PF6]
2+, m/z 1399.78. calc. for Ru3[C128H124N18](PF6)4
2+, m/z
1399.30. [{Ru(phen)2}(µ-bb10){Ru(phen)}(µ-bb10){Ru(phen)2}]-
(PF6)6. Anal. Calcd for C124H116N18F36P6Ru3: C, 49.1%; H,
3.86%; N, 8.3%. Found: C, 48.8%; H, 3.84%; N, 8.2%. 1H NMR
(400 MHz, CD3CN): δ 8.68–8.61 (m, 5H); 8.57–8.50 (m, 5H);
8.42–8.33 (m, 8H); 8.28–8.16 (m, 18H); 7.90–7.85 (m, 5H);
7.81–7.76 (m, 5H); 7.57–7.52 (m, 8H); 7.51–7.45 (m, 5H);
7.13–7.08 (m, 5H); 2.82–2.70 (m, 8H); 2.56 (s, 3H); 2.51 (s, 6H);
2.47 (s, 3H); 1.73–1.58 (m, 8H); 1.43–1.22 (m, 24H). 13C NMR
(CD3CN): δ 157.8, 157.74, 157.6, 155.6, 155.1, 153.56, 153.51,
153.3, 152.3, 152.1, 151.2, 148.8, 148.5, 137.54, 137.42, 131.8,
129.0, 128.9, 128.3, 126.8, 126.7, 125.7, 124.9, 35.6, 30.9, 30.8,
30.3, 30.2, 30.09, 30.01, 29.9, 29.6, 21.1 and 20.9. TOF MS
(ESI+): most abundant ion found for [M − 4PF6]4+, m/z 612.89.
Calc. for Ru3[C124H116N18](PF6)2
4+, m/z 612.89; most abundant
ion found for [M − 3PF6]3+, m/z 865.52. Calc. for
Ru3[C124H116N18](PF6)3
3+, m/z 865.50; most abundant ion
found for [M − 2PF6]2+, m/z 1370.76. calc. for Ru3[C124H116N18]-
(PF6)4
2+, m/z 1370.74.
The chloride salts were obtained by stirring the PF6
− salts
in methanol with Amberlite IRA-402 (chloride form) anion-
exchange resin for 1–2 h until the solution was clear. The resin
was removed by filtration, and the orange-red solution was
evaporated and the solid dried in an oven at 70 °C for 16 h to
obtain dark red solid of [{Ru(phen)2}(µ-bbn){Ru(phen)}(µ-bbn)-
{Ru(phen)2}]Cl6 (Rubbn-tri), typical yields were 25–30%, based
on the synthetic starting material [Ru(phen)2(bbn)](PF6)2.
[{Ru(phen)2}(µ-bbn){Ru(phen)}(µ-bbn){Ru(phen)}(µ-bbn){Ru-
(phen)2}]Cl8 (Rubbn-tetra). In a typical reaction, [{Ru(phen)2}-
(µ-bb16){Ru(phen)Cl2}](PF6)2 (95 mg, 0.057 mmol) was dis-
solved in ethanol–water (1 : 1, 50 mL) and bb16 ligand (32 mg,
0.057 mmol) was added and the reaction mixture heated at
reflux for 4 h in the dark under a nitrogen atmosphere. The
colour of the reaction slowly turned from dark brown to dark
red during the course of the reaction. The reaction mixture
was cooled to room temperature and the solvent was evapor-
ated under reduced pressure to obtain a dark orange-red solid,
which was then converted to the chloride salt by stirring in
methanol with Amberlite IRA-402 (chloride form) anion-
exchange resin. After filtration of the resin, the methanol was
evaporated to obtain the chloride salt which was dissolved in
water (10 mL) and loaded onto an SP-Sephadex C-25 cation
exchange column (2 cm diam. × 25 cm), the column washed
with water and eluted with 0.6 M and then 0.8 M NaCl solu-
tions to remove the impurities. The desired tetranuclear
complex was eluted with a 1 M NaCl solution containing 30%
acetone. After removing the acetone, solid KPF6 was added to
the eluate followed by extraction into DCM (2 × 20 mL). The
organic layer was washed with water (20 mL), dried over anhy-
drous Na2SO4, and evaporated to dryness to obtain the PF6
−
salt of the complex. The complex was further purified using
Sephadex LH-20 with acetone as the eluent. The major first
orange band was collected, the acetone evaporated and the
resultant solid crystallised from acetonitrile–toluene to yield a
bright red-orange precipitate of [{Ru(phen)2}(µ-bb16)-
{Ru(phen)}(µ-bb16){Ru( phen)}(µ-bb16){Ru( phen)2}](PF6)8.
[{Ru(phen)2}(µ-bb16){Ru(phen)}(µ-bb16){Ru(phen)}(µ-bb16){Ru-
(phen)2}](PF6)8. Anal. Calcd for C186H198N24F48P8Ru4: C,
51.5%; H, 4.61%; N, 7.8%. Found: C, 51.4%; H, 4.42%; N,
7.8%. 1H NMR (400 MHz, CD3CN): δ 8.66–8.52 (m, 16H);
8.42–8.34 (m, 10H); 8.30–8.18 (m, 18H); 7.91–7.86 (m, 8H);
7.83–7.77 (m, 8H); 7.55 (m, 12H); 7.51–7.46 (m, 6H); 7.11 (m,
6H); 2.76 (m, 12H); 2.57 (s, 3H); 2.51 (s, 12H); 2.47 (s, 3H);
1.74–1.58 (m, 12H); 1.43–1.14 (m, 72H). 13C NMR (CD3CN):
δ 157.8, 157.75, 156.9, 155.6, 153.55, 153.50, 153.46, 152.2,
152.1, 151.2, 148.8, 148.5, 137.5, 137.4, 131.85, 131.82, 128.9,
128.8, 128.7, 128.2, 126.8, 126.7, 125.6, 124.9, 35.6, 30.8, 30.7,
30.4, 30.3, 30.24, 30.19, 30.05, 30.01, 29.8, 29.7, 21.1 and 20.6.
TOF MS (ESI+): most abundant ion found for [M − 6PF6]6+, m/z
577.36. Calc. for Ru4[C186H198N24] (PF6)2
6+, m/z 577.33; most
abundant ion found for [M − 4PF6]4+, m/z 938.55. Calc. for
Ru4[C186H198N24](PF6)4
4+, m/z 938.48; most abundant ion
found for [M − 3PF6]3+, m/z 1299.40. Calc. for Ru4[C186H198N24]-
(PF6)5
3+, m/z 1299.63. [{Ru(phen)2}(µ-bb12){Ru(phen)}(µ-bb12)-
{Ru(phen)}(µ-bb12){Ru(phen)2}](PF6)8. Anal. Calcd for
C174H174N24F48P8Ru4: C, 50.2%; H, 4.21%; N, 8.1%. Found: C,
50.2%; H, 4.35%; N, 8.0%. 1H NMR (400 MHz, CD3CN): δ
8.68–8.50 (m, 16H); 8.43–8.33 (m, 10H); 8.29–8.22 (m, 10H);
8.21–8.16 (m, 8H); 7.88 (m, 8H); 7.82–7.75 (m, 8H); 7.59–7.52
(m, 12H); 7.48 (m, 6H); 7.10 (m, 6H); 2.75 (m, 12H); 2.59 (s,
3H); 2.51 (s, 12H); 2.46 (s, 3H); 1.71–1.57 (m, 12H); 1.43–1.21
(m, 48H). 13C NMR (CD3CN): δ 157.79, 157.73, 155.6, 153.55,
153.52, 153.48, 152.29, 152.17, 151.2, 148.8, 148.5, 137.52,
137.41, 131.85, 131.81, 128.95, 128.91, 128.86, 128.1, 126.8,
126.7, 125.7, 124.9, 35.6, 30.8, 30.6, 30.35, 30.27, 30.23, 30.16,
30.04, 29.9, 29.8, 29.7, 21.1 and 20.5. TOF MS (ESI+): most
abundant ion found for [M − 6PF6]6+, m/z 549.47. Calc. for
Ru4[C174H174N24](PF6)2
6+, m/z 549.28; most abundant ion
found for [M − 5PF6]5+, m/z 688.18. Calc. for Ru4[C174H174N24]-
(PF6)3
5+, m/z 688.13; most abundant ion found for
[M − 4PF6]4+, m/z 896.73. Calc. for Ru4[C174H174N24](PF6)44+,
m/z 896.40. [{Ru(phen)2}(µ-bb10){Ru(phen)}(µ-bb10){Ru(phen)}-
(µ-bb10){Ru(phen)2}](PF6)8. Anal. Calcd for C168H162N24F48P8Ru4:
C, 49.4%; H, 4.00%; N, 8.2%. Found: C, 49.4%; H, 3.92%; N,
Paper Dalton Transactions
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8.0%. 1H NMR (400 MHz, CD3CN): δ 8.68–8.51 (m, 16H);
8.41–8.33 (m, 10H); 8.28–8.22 (m, 10H); 8.21–8.15 (m, 8H);
7.87 (m, 8H); 7.81–7.76 (m, 8H); 7.54 (m, 12H); 7.50–7.46
(m, 6H); 7.12 (m, 6H); 2.78 (m, 12H); 2.56 (s, 3H); 2.51
(s, 12H); 2.45 (s, 3H); 1.73–1.56 (m, 12H); 1.45–1.22 (m, 36H).
13C NMR (CD3CN): δ 157.8, 157.7, 155.6, 153.56,
153.51, 153.46, 152.3, 152.2, 151.2, 148.8, 148.5, 137.5, 137.4,
131.8, 131.6, 128.94, 128.89, 128.82, 128.2, 126.8, 126.7,
125.6, 124.9, 35.6, 30.9, 30.6, 30.3, 30.2, 30.16, 30.08, 30.01,
29.9, 29.8, 29.7, 21.1 and 20.8. TOF MS (ESI+): most
abundant ion found for [M − 5PF6]5+, m/z 671.40. Calc. for
Ru4[C168H162N24](PF6)3
5+, m/z 671.29; most abundant ion
found for [M − 4PF6]4+, m/z 875.77. Calc. for Ru4[C168H162N24]-
(PF6)4
4+, m/z 875.36; most abundant ion found for [M −
3PF6]
3+, m/z 1215.32. Calc. for Ru4[C168H162N24](PF6)5
3+, m/z
1215.47.
The chloride salts were obtained by stirring the PF6
− salts
in methanol with Amberlite IRA-402 (chloride form) anion-
exchange resin. The resin was removed by filtration, and the
orange-red solution was evaporated and dried in oven at 70 °C
for 16 h to obtain dark red [{Ru(phen)2}(µ-bbn){Ru(phen)}-
(µ-bbn){Ru(phen)}(µ-bbn){Ru(phen)2}]Cl8 (Rubb16-tetra), typical
yields were 20–25%, based on the synthetic starting material
[{Ru(phen)2}(µ-bbn){Ru(phen)Cl2}](PF6)2.
[{Ru(µ-bbn)3}{Ru(phen)2}3]Cl8 (Rubbn-tetra-nl). In a typical
reaction, a mixture of [Ru(phen)2(bb16)](PF6)2 (229 mg,
0.174 mmol) and cis-[Ru(DMSO)4Cl2] (28 mg, 0.057 mmol)
was heated to reflux in ethanol–water (1 : 1, 20 mL) for 5–6 h
under the nitrogen atmosphere. The reaction mixture was
cooled to room temperature and the solvent evaporated to
obtain an orange solid which was converted to the chloride
salt by stirring in methanol with Amberlite IRA-402 (chloride
form) anion-exchange resin. After filtration of the resin and
removal of methanol, the solid was dissolved in water (10 mL)
and loaded onto an SP-Sephadex C-25 cation exchange column
(2 cm diam. × 25 cm), eluted with water and then with 0.6 M
and then 0.8 M NaCl solutions to remove the impurities. The
desired non-linear tetranuclear complex was eluted with a 1 M
NaCl solution containing 30% acetone. After removing the
acetone, solid KPF6 was added to the eluate followed by extrac-
tion into DCM (2 × 20 mL). The organic layer was washed with
water (20 mL), dried over anhydrous Na2SO4, and evaporated
to dryness to obtain the PF6
− salt of the complex. The complex
was further purified using Sephadex LH-20 with acetone as the
eluent, the major first orange band was collected and the
acetone evaporated to yield a bright red-orange solid of [{Ru(µ-
bb16)3}{Ru(phen)2}3](PF6)8. [{Ru(µ-bb16)3}{Ru(phen)2}3](PF6)8.
Anal. Calcd for C186H198N24F48P8Ru4: C, 51.5%; H, 4.61%; N,
7.8%. Found: C, 51.2%; H, 4.66%; N, 7.7%. 1H NMR
(400 MHz, CD3CN): δ 8.67–8.62 (m, 8H); 8.57–8.51 (m, 8H);
8.44–8.36 (m, 10H); 8.26–8.22 (m, 10H); 8.21–8.18 (m, 8H);
7.92–7.84 (m, 8H); 7.82–7.76 (m, 8H); 7.58–7.52 (m, 12H);
7.49–7.45 (m, 6H); 7.14–7.07 (m, 6H); 2.74 (m, 12H); 2.64 (s,
3H); 2.54 (s, 12H); 2.44 (s, 3H); 1.73–1.57 (m, 12H); 1.44–1.16
(m, 72H). 13C NMR (CD3CN): δ 157.8, 157.7, 156.9, 156.5,
156.3, 155.7, 154.8, 153.7, 153.57, 153.53, 153.49, 152.3, 152.2,
151.2, 148.8, 148.6, 137.5, 137.4, 131.8, 129.0, 128.9, 128.8,
128.2, 126.8, 126.7, 125.7, 124.9, 35.6, 30.9, 30.6, 30.48, 30.40,
30.3, 30.2, 30.1, 30.04, 29.96, 29.91, 28.5, 21.1 and 20.7. TOF
MS (ESI+): most abundant ion found for [M − 8PF6]8+, m/z
396.77. Calc. for Ru4[C186H198N24]
8+, m/z 396.76; most abun-
dant ion found for [M − 7PF6]7+, m/z 474.10. Calc. for
Ru4[C186H198N24](PF6)1
7+, m/z 474.14; most abundant ion
found for [M − 5PF6]5+, m/z 721.90. Calc. for Ru4[C186H198N24]-
(PF6)3
5+, m/z 721.79. [{Ru(µ-bb12)3}{Ru(phen)2}3](PF6)8·4H2O.
Anal. Calcd for C174H182N24F48O4P8Ru4: C, 49.3%; H, 4.33%;
N, 7.9%. Found: C, 48.9%; H, 4.36%; N, 7.6%. 1H NMR
(400 MHz, CD3CN): δ 8.68–8.63 (m, 8H); 8.56–8.52 (m, 8H);
8.42–8.34 (m, 10H); 8.28–8.22 (m, 10H); 8.21–8.17 (m, 8H);
7.90–7.86 (m, 8H); 7.84–7.78 (m, 8H); 7.57–7.52 (m, 12H);
7.50–7.46 (m, 6H); 7.13–7.08 (m, 6H); 2.77 (m, 12H); 2.62 (s,
3H); 2.52 (s, 12H); 2.45 (s, 3H); 1.71–1.56 (m, 12H); 1.41–1.14
(m, 48H). 13C NMR (CD3CN): δ 157.8, 157.7, 156.8, 156.2,
156.0, 155.6, 154.5, 153.9, 153.6, 153.4, 152.3, 152.2, 151.2,
148.8, 148.6, 137.5, 137.4, 131.8, 129.0, 128.95, 128.89, 128.2,
126.8, 126.7, 125.7, 124.9, 35.6, 30.9, 30.7, 30.4, 30.3, 30.2,
30.1, 30.06, 30.02, 29.9, 29.3, 28.3, 21.2 and 21.1. TOF MS
(ESI+): most abundant ion found for [M − 8PF6]8+, m/z 375.75.
Calc. for Ru4[C174H174N24]
8+, m/z 375.71; most abundant ion
found for [M − 7PF6]7+, m/z 450.00. Calc. for Ru4[C174H174N24]-
(PF6)1
7+, m/z 450.10; most abundant ion found for [M −
6PF6]
6+, m/z 549.16. Calc. for Ru4[C174H174N24](PF6)2
6+, m/z
549.28; most abundant ion found for [M − 5PF6]5+, m/z 688.18.
Calc. for Ru4[C174H174N24](PF6)3
5+, m/z 688.13. [{Ru(µ-bb10)3}-
{Ru(phen)2}3](PF6)8·4H2O. Anal. Calcd for
C168H170N24F48O4P8Ru4: C, 48.6%; H, 4.13%; N, 8.1%. Found:
C, 48.5%; H, 4.37%; N, 7.7%. 1H NMR (400 MHz, CD3CN):
δ 8.69–8.62 (m, 8H); 8.57–8.52 (m, 8H); 8.44–8.31 (m, 10H);
8.29–8.22 (m, 10H); 8.21–8.16 (m, 8H); 7.91–7.85 (m, 8H);
7.82–7.76 (m, 8H); 7.58–7.52 (m, 12H); 7.51–7.46 (m, 6H);
7.13–7.07 (m, 6H); 2.76 (m, 12H); 2.60 (s, 3H); 2.54 (s, 12H);
2.44 (s, 3H); 1.72–1.60 (m, 12H); 1.42–1.20 (m, 36H). 13C NMR
(CD3CN): δ 157.8, 157.7, 157.0, 156.9, 156.4, 155.9, 155.6,
155.3, 153.57, 153.52, 153.4, 153.3, 152.3, 152.1, 151.2, 150.8,
148.8, 148.5, 137.5, 137.4, 131.8, 128.96, 128.90, 128.2, 126.8,
126.7, 125.7, 124.9, 35.6, 30.96, 30.91, 30.6, 30.2, 30.08, 30.01,
29.8, 29.3, 28.3, 21.2 and 20.9. TOF MS (ESI+): most abundant
ion found for [M − 5PF6]5+, m/z 671.36. Calc. for
Ru4[C168H162N24](PF6)3
5+, m/z 671.29; most abundant ion
found for [M − 4PF6]4+, m/z 875.45. Calc. for Ru4[C168H162N24]
(PF6)4
4+, m/z 875.36; most abundant ion found for [M −
3PF6]
3+, m/z 1215.60. Calc. for Ru4[C168H162N24](PF6)5
3+, m/z
1215.47; most abundant ion found for [M − 2PF6]2+, m/z
1895.85. Calc. for Ru4[C168H162N24](PF6)6
2+, m/z 1895.69.
The chloride salts were obtained by stirring the PF6
−
salts in methanol with Amberlite IRA-402 (chloride form)
anion-exchange resin. The resin was removed by filtration,
and the orange-red solution was evaporated and dried in
oven at 70 °C for 16 h to obtain dark red [{Ru(µ-bbn)3}-
{Ru(phen)2}3}]Cl8 (Rubbn-tetra-nl), typical yields were
25–35%, based on the synthetic starting material
[Ru(DMSO)4Cl2].
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